Literature DB >> 10630509

Mortality and causes of death in celiac disease in a Mediterranean area.

M Cottone1, A Termini, L Oliva, A Magliocco, C Marrone, A Orlando, F Pinzone, R Di Mitri, M Rosselli, A Rizzo, L Pagliaro.   

Abstract

No data on mortality in celiac disease are currently available in southern Europe. Our aim was to evaluate mortality and the cause of death in adult celiac disease in a Mediterranean area. In all, 228 adults with celiac disease were histologically diagnosed in our department from 1980 to 1997. Full information on their state of health was obtained in 216 of 228 patients. A tabulation of patient-years at risk was constructed in terms of age at diagnosis and the interval from diagnosis. Standardized mortality ratio was calculated by dividing the number of observed deaths by the number of expected deaths. Twelve deaths were observed, whereas 3.12 deaths were expected (SMR = 3.8; 95% CI 2-7). The increased mortality was mainly observed within four years from diagnosis (8 observed; 1.4 expected) (SMR = 5.8; 95% CI 2.5-11.5). Twelve tumors were observed (six lymphomas). In conclusion, mortality from adult celiac disease in our geographical area is increased compared with the general population, and this increased risk seems due to non-Hodgkin's lymphoma.

Entities:  

Mesh:

Year:  1999        PMID: 10630509     DOI: 10.1023/a:1026655609906

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

Review 1.  Celiac sprue.

Authors:  J S Trier
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

Review 2.  Coeliac disease.

Authors:  M Mäki; P Collin
Journal:  Lancet       Date:  1997-06-14       Impact factor: 79.321

3.  Malignancy in coeliac disease--effect of a gluten free diet.

Authors:  G K Holmes; P Prior; M R Lane; D Pope; R N Allan
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

4.  Malignancy in a 19-year experience of adult celiac disease.

Authors:  W S Selby; N D Gallagher
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

5.  Coeliac disease and malignancy.

Authors:  C M Swinson; G Slavin; E C Coles; C C Booth
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

6.  Adenocarcinoma of the upper small bowel complicating coeliac disease.

Authors:  G K Holmes; G I Dunn; R Cockel; V S Brookes
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

7.  Coeliac disease in the elderly.

Authors:  G L Hankey; G K Holmes
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  Lymphoma risk in coeliac disease of later life.

Authors:  B T Cooper; G K Holmes; W T Cooke
Journal:  Digestion       Date:  1982       Impact factor: 3.216

9.  Mortality in celiac disease.

Authors:  R F Logan; E A Rifkind; I D Turner; A Ferguson
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

10.  Coeliac disease--associated disorders and survival.

Authors:  P Collin; T Reunala; E Pukkala; P Laippala; O Keyriläinen; A Pasternack
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

View more
  17 in total

1.  Population based screening for coeliac disease: patient's choice or doctor's decision.

Authors:  S Ishaq
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 2.  Recent advances in coeliac disease.

Authors:  D A van Heel; J West
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 4.  Mortality in celiac disease.

Authors:  Federico Biagi; Gino R Corazza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02-02       Impact factor: 46.802

Review 5.  Refractory celiac disease: from bench to bedside.

Authors:  Georgia Malamut; Bertrand Meresse; Christophe Cellier; Nadine Cerf-Bensussan
Journal:  Semin Immunopathol       Date:  2012-07-19       Impact factor: 9.623

Review 6.  Pathogenesis of Enteropathy-Associated T Cell Lymphoma.

Authors:  Udit Chander; Rebecca J Leeman-Neill; Govind Bhagat
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

7.  Canadian consensus on medically acceptable wait times for digestive health care.

Authors:  William G Paterson; William T Depew; Pierre Paré; Denis Petrunia; Connie Switzer; Sander J Veldhuyzen van Zanten; Sandra Daniels
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

8.  Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association.

Authors:  Ying Gao; Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

9.  Malignancy and mortality in people with coeliac disease: population based cohort study.

Authors:  Joe West; Richard F A Logan; Chris J Smith; Richard B Hubbard; Timothy R Card
Journal:  BMJ       Date:  2004-07-21

10.  Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach.

Authors:  Antonio Carroccio; Emilio Iannitto; Lidia Di Prima; Sonia Cirrincione; Riccardo Troncone; Franco Paparo; Lydia Gianni Trapani; Antonio Gucciardi; Maurizio R Averna; Giuseppe Montalto; Alberto Notarbartolo
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.